PCG
IMA

Private Capital Group’s ImageneBio Inc IMA Stock Holding History

Private Capital Group’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1K Buy
+21
New +$1.16K ﹤0.01% 1719

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Private Capital Group's IMA Position: Q2 2022 in Review

Private Capital Group opened a new position in ImageneBio Inc (IMA) in Q2 2022: 21 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1719 among its holdings.

46 funds tracked by Wall St. Rank hold IMA as of Q2 2022.

  • Private Capital Group held 21 shares of ImageneBio Inc worth $1K as of Q2 2022.
  • ImageneBio Inc was a new Private Capital Group position in Q2 2022.
  • ImageneBio Inc made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1719 holding.
  • 46 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.